Johannesburg - The merged entity from Mediclinic’s reverse takeover of London-listed Al Noor Hospitals Group is set for a FTSE 100 debut at the March review, according to Investec.
The transaction will create the third-largest hospital group outside the US and is expected to be completed on February 15.
The new company’s market capitalisation will be £6 billion (R135.40bn). Mediclinic and Al Noor last year agreed on terms valuing Al Noor at £11.60 a share.
The company has operations in southern Africa, the Middle East and Switzerland. Mediclinic shares were down 0.91 percent at R119.40 at the close of the JSE yesterday.
BUSINESS REPORT